China’s State Council Releases Policies On Bioindustry Development
This article was originally published in PharmAsia News
China's State Council recently issued stimulus measures for speeding up local bioindustry development. Highlighted is the channelling of private capital to encourage establishment of investment institutions, as well as funds for biotechnology. The state will support the listing of local bioenterprises on the Small and Medium Enterprises Board and Growth Enterprise Board; encourage qualified biotech companies to raise funds via domestic or overseas listings, as well as issue corporate bonds, short-term financing bonds and medium-term notes; conduct share-transfer pilots and by tapping securities firms to promote equity rights circulation and broaden channels for investment. In addition, the government will set up coordination mechanisms at the ministry level to oversee key issues during the industry development. (Click here for more - Chinese Language)
You may also be interested in...
Experts from the University of Chicago are advocating for helmet ventilation for COVID-19 patients. Medtech Insight spoke to acute nurse practitioner Aurika Savickaite who is helping lead an initiative to educate and raise awareness of the technology.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.
The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.